These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
484 related articles for article (PubMed ID: 1542323)
21. Urologic diseases in America project: urinary incontinence in women-national trends in hospitalizations, office visits, treatment and economic impact. Thom DH; Nygaard IE; Calhoun EA J Urol; 2005 Apr; 173(4):1295-301. PubMed ID: 15758785 [TBL] [Abstract][Full Text] [Related]
22. The direct economic costs of insomnia in the United States for 1995. Walsh JK; Engelhardt CL Sleep; 1999 May; 22 Suppl 2():S386-93. PubMed ID: 10394612 [TBL] [Abstract][Full Text] [Related]
23. The effect of first-contact care with primary care clinicians on ambulatory health care expenditures. Forrest CB; Starfield B J Fam Pract; 1996 Jul; 43(1):40-8. PubMed ID: 8691179 [TBL] [Abstract][Full Text] [Related]
24. The economic burden of smoking in California. Max W; Rice DP; Sung HY; Zhang X; Miller L Tob Control; 2004 Sep; 13(3):264-7. PubMed ID: 15333882 [TBL] [Abstract][Full Text] [Related]
25. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 2001-02. Schappert SM; Burt CW Vital Health Stat 13; 2006 Feb; (159):1-66. PubMed ID: 16471269 [TBL] [Abstract][Full Text] [Related]
26. The burden of illness associated with renal cell carcinoma in the United States. Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652 [TBL] [Abstract][Full Text] [Related]
27. Urologic diseases in America project: urinary incontinence in males--demographics and economic burden. Stothers L; Thom D; Calhoun E J Urol; 2005 Apr; 173(4):1302-8. PubMed ID: 15758786 [TBL] [Abstract][Full Text] [Related]
28. Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysema. Wilson L; Devine EB; So K Respir Med; 2000 Mar; 94(3):204-13. PubMed ID: 10783930 [TBL] [Abstract][Full Text] [Related]
29. Healthcare utilization and costs of patients with rosacea in an insured population. Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697 [TBL] [Abstract][Full Text] [Related]
30. The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991. Jacobson L; Hertzman P; Löfdahl CG; Skoogh BE; Lindgren B Respir Med; 2000 Mar; 94(3):247-55. PubMed ID: 10783936 [TBL] [Abstract][Full Text] [Related]
31. Economic burden of cancer across the European Union: a population-based cost analysis. Luengo-Fernandez R; Leal J; Gray A; Sullivan R Lancet Oncol; 2013 Nov; 14(12):1165-74. PubMed ID: 24131614 [TBL] [Abstract][Full Text] [Related]
32. Cost of depression in Europe. Sobocki P; Jönsson B; Angst J; Rehnberg C J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486 [TBL] [Abstract][Full Text] [Related]
33. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids. Friedman HS; Yawn BP Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696 [TBL] [Abstract][Full Text] [Related]
34. Resource costs for asthma-related care among pediatric patients in managed care. Gendo K; Sullivan SD; Lozano P; Finkelstein JA; Fuhlbrigge A; Weiss KB Ann Allergy Asthma Immunol; 2003 Sep; 91(3):251-7. PubMed ID: 14533656 [TBL] [Abstract][Full Text] [Related]
35. Resource utilization and costs of treating severe rotavirus diarrhea in young Mexican children from the health care provider perspective. Granados-García V; Velázquez-Castillo R; Garduño-Espinosa J; Torres-López J; Muñoz-Hernández O Rev Invest Clin; 2009; 61(1):18-25. PubMed ID: 19507471 [TBL] [Abstract][Full Text] [Related]
36. Cost impact of COPD in Japan: opportunities and challenges? Nishimura S; Zaher C Respirology; 2004 Nov; 9(4):466-73. PubMed ID: 15612957 [TBL] [Abstract][Full Text] [Related]